Cash Flow from Operating Activities: A company's cash flows from operations.
Edesa Biotech, Inc. (EDSA) had Cash Flow from Operating Activities of $-2.09M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.25M |
|
-- |
|
-- |
|
$2.34M |
|
$-2.34M |
|
$0.09M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.25M |
|
$-2.34M |
|
$-2.32M |
|
7.97M |
|
7.97M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$12.72M |
|
-- |
|
$1.99M |
|
$14.71M |
|
$0.76M |
|
-- |
|
-- |
|
$0.76M |
|
$4.66M |
|
$12.00M |
|
$13.95M |
|
8.33M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-2.09M |
-- |
|
$3.36M |
|
$10.79M |
|
$12.05M |
|
$1.26M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.27% |
|
-18.73% |
|
-15.28% |
|
-16.11% |
|
$1.67 |
|
$-0.26 |
|
$-0.26 |
|